Stay updated on Psilocybin Effects in Depressed Patients: Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Effects in Depressed Patients: Clinical Trial page.

Latest updates to the Psilocybin Effects in Depressed Patients: Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the completed ClinicalTrials.gov record for a University of Zurich study of psilocybin for major depression, including its design, eligibility criteria, outcomes, and publications.SummaryDifference48%

- Check12 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide notice appears above the navigation announcing an NIH website transition and a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous content with an access-restricted page.SummaryDifference0.5%

Stay in the know with updates to Psilocybin Effects in Depressed Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Effects in Depressed Patients: Clinical Trial page.